A tiny magnetic sheet robot folds itself to navigate the stomach and deliver drugs

The human gastrointestinal tract is not a friendly environment for machines. It is acidic, constantly moving, irregularly shaped, and filled with fluid. Yet millions of people with GI diseases need medications delivered precisely where the damage is - and swallowing a pill that distributes drugs throughout the entire body is a blunt instrument for a problem that demands precision.

A research team spanning four universities across China, Germany, and the United Kingdom has built what amounts to a tiny origami robot designed to navigate this hostile terrain. The device - a four-layer soft sheet just 30 millimeters long, 10 millimeters wide, and 1.5 millimeters thick - can fold itself to one-third of its surface area to squeeze through narrow intestinal passages, then unfold for stable movement in the larger stomach cavity. All of this is controlled by external magnetic fields, with no batteries, motors, or tethers.

Fluid that becomes magnetic on demand

The key innovation is the robot's core material: magnetorheological fluid, a suspension of microscopic magnetic particles in a carrier liquid. In the absence of a magnetic field, the fluid is essentially non-magnetic - meaning the robot will not cause unintended interference inside the human body. Apply a magnetic field, and the particles snap into chains within milliseconds, creating a magnetized structure whose orientation can be dynamically adjusted.

This gives the robot something its predecessors lacked: real-time reconfigurable magnetization. Existing magnetic soft robots typically have their magnetic orientation fixed during manufacturing, limiting their ability to adapt to the unpredictable geometry of the GI tract. The magnetorheological approach allows the robot to change its folding angle, direction, and motion pattern on the fly, driven by a 5-degree-of-freedom magnetic field platform.

The robot's four layers - upper and lower polyethylene surfaces, the magnetorheological fluid core, and a polyamide nylon mesh for structural support - weigh just 0.55 grams total.

Five minutes to the target, thirty to deliver the payload

The team built five prototypes with different fluid densities (ranging from 3.0 to 4.2 grams per milliliter) and tested them across multiple scenarios: smooth surfaces, flexible fluff surfaces, slopes, and underwater environments. The robot demonstrated stable flipping, steering, and folding motions in all conditions.

The critical validation came in ex vivo porcine stomach experiments. In 10 repeated trials, the robot navigated to preset lesion sites within an average of five minutes, attached stably to the drug release position, and delivered its payload - a biodegradable hydrogel carrying approximately 30% of the robot's own mass - which dissolved within 30 minutes for localized therapy. Ultrasonic imaging (using a Voluson E10 system) successfully tracked the robot's real-time movement within the closed gastric cavity.

Surviving stomach acid

Biocompatibility testing addressed the obvious concern: can this thing survive inside a human body without causing harm? The robot was immersed in simulated gastric juice (pH 1.2) and intestinal fluid (pH 6.8) at body temperature for 24 hours. It showed no surface rupture, volume expansion, or shape deformation. Heavy metal and harmful substance levels in the extract solutions stayed within safety limits, and microbial culture tests showed no bacterial growth.

These are encouraging results, though they represent lab-bench safety testing rather than in vivo trials. The gap between surviving in a beaker of simulated stomach acid and functioning safely inside a living human body is substantial.

What still needs solving

The research team, led by Xinhua Liu at China University of Mining and Technology with collaborators at Soochow University, RWTH Aachen University, and the University of Oxford, acknowledges several challenges ahead. The acidic gastric environment, peristaltic contractions, and fluid disturbances in a living GI tract will be harder to navigate than a stationary ex vivo stomach. The coordination between magnetic field control and ultrasonic detection needs refinement for real clinical use.

There is also the matter of the 5-degree-of-freedom magnetic field platform required to drive the robot. In the current setup, this is a laboratory instrument, not something that could be deployed in a standard endoscopy suite. Miniaturizing and integrating the control system into clinical equipment will be a significant engineering effort.

But the fundamental proof of concept is compelling. A robot that can reconfigure its shape in real time, navigate complex biological terrain without any physical connection, deliver a drug payload precisely to a target site, and dissolve its medication on a predictable timeline - that is a meaningful step toward replacing systemic drug delivery with something far more targeted.

The work was supported by the National Natural Science Foundation of China and the Natural Science Foundation of Jiangsu Province.